Doxycycline or oral corticosteroids for nasal polyps

Area of Science:

• Otolaryngology
• Pharmacology
• Clinical Trials

Background:

• Nasal polyps significantly impact quality of life.
• Recurrent or severe nasal polyps often require medical or surgical intervention.
• Limited evidence exists comparing antibiotic and corticosteroid efficacy for severe nasal polyps.

Purpose of the Study:

• To compare the efficacy of doxycycline versus methylprednisolone in treating severe nasal polyps.
• To evaluate the impact of these treatments on nasal polyp scores.

Main Methods:

• Randomized, double-blind, placebo-controlled trial.
• 20-day treatment with either doxycycline (100-200 mg/day) or a tapering methylprednisolone schedule.
• Nasal polyp score (0-8) assessed at baseline and weeks 1, 2, 4, 8, and 12.
• Included patients with recurrent or massive (grade 3-4) nasal polyps.

Main Results:

• Both doxycycline and methylprednisolone groups showed positive results in reducing nasal polyp scores.
• The patient population had severe disease (average polyp score ~6), potentially limiting generalizability.
• The study design was robust, employing a randomized, double-blind, placebo-controlled methodology.

Conclusions:

• Doxycycline and methylprednisolone appear effective for severe nasal polyps.
• Results may not apply to patients with less severe nasal polyp disease.
• Further investigation is warranted to confirm findings and explore treatment applicability across different disease severities.